News

Crescendo Claims Triple Knockout Mice Lack IgH and Kappa/Lambda Light Chains September 29, 2010. Company will combine mouse tech with YAC platform to generate human heavy chain drugs. U.K ...
In fact, the kappa/lambda ratio showed excess kappa chains in about 90 percent of the patients who had an abnormal ratio without a tumor of the plasma cells, the investigators say.
In fact, the kappa/lambda ratio showed excess kappa chains in about 90 percent of the patients who had an abnormal ratio without a tumor of the plasma cells, the investigators say.
Immunohistochemistry for AA (Novocastra, UK), transthyrethin (TTR) (DAKO, Denmark), and cytoplasmic kappa and lambda immunoglobulins light chains was performed on paraffin-embedded sections.
MINNEAPOLIS, May 10, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic ...
PhenomeX Inc., a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon® platform at the 16th annual Conference ...
Due to the low utilization of Immunoglobulin Lambda genes in wildtype mice (about 5%, varying by strain), antibodies with Lambda light chain (λ-antibodies) have always been under-scrutinized.